<DOC>
	<DOCNO>NCT02434315</DOCNO>
	<brief_summary>The purpose study evaluate impact vary amount FreeStyle Libre Pro wear measured time range .</brief_summary>
	<brief_title>FreeStyle Libre Pro Use Primary &amp; Secondary Care</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Age least 18 year . Type 2 diabetes treat insulin therapy least 6 month prior study enrolment . HbA1c 58 108 mmol/mol ( 7.5 12.0 % ) inclusive . Age least 18 year . Type 2 diabetes treat insulin therapy least 6 month prior study enrolment . HbA1c 58 108 mmol/mol ( 7.5 12.0 % ) inclusive . Participant currently prescribe animal insulin . Total daily dose insulin ( TDD ) &gt; 1.75 iu/kg entry study . Concomitant disease condition may compromise patient safety include limited ; cystic fibrosis , severe mental illness , diagnose suspect eat disorder uncontrolled long term medical condition . Has pacemaker neurostimulators . Currently prescribed oral , intramuscular intravenous steroid therapy acute chronic condition require study period . Currently receive dialysis treatment plan receive dialysis study . Women pregnant , plan become pregnant become pregnant study . Participating another study glucose monitoring device drug could affect glucose measurement management . Currently use / previously use sensor base Glucose Monitoring System ( include retrospective glucose monitoring system ) within last 6 month . Currently use Continuous Subcutaneous Insulin Infusion ( CSII ) . Known ( suspect ) allergy medical grade adhesive . In investigator 's opinion participant unsuitable participate due cause/reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Sensing Technology</keyword>
</DOC>